Durvalumab

Item number	Size	Delivery time	Price
TGM-T11126-1mg	1 mg	5 - 10 business days*	215.00€
TGM-T11126-5mg	5 mg	5 - 10 business days*	510.00€
TGM-T11126-10mg	10 mg	5 - 10 business days*	736.00€
TGM-T11126-25mg	25 mg	5 - 10 business days*	1,118.00€
TGM-T11126-50mg	50 mg	5 - 10 business days*	1,507.00€
TGM-T11126-100mg	100 mg	5 - 10 business days*	2,019.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Durvalumab (MEDI 4736) is a humanized monoclonal antibody targeting PD-L1. It can... more

Close menu

Product information "Durvalumab"

Description: Durvalumab (MEDI 4736) is a humanized monoclonal antibody targeting PD-L1. It can block the interaction of PD-L1 with PD-1 and CD80, with IC50 values of 0.1 and 0.04 nM, respectively. Durvalumab is often used in combination with platinum-based compounds for the treatment of non-small cell lung cancer and advanced hepatocellular carcinoma cells. Target: PD-1/PD-L1. References: Faiena I, et al. Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma. Drug Des Devel Ther. 2018 Jan 23,12:209-215.

Keywords:	MEDI 4736
Supplier:	TargetMol
Supplier-Nr:	T11126

Properties

Conjugate:

Database Information

CAS :	1428935-60-7\| Matching products
KEGG ID :	K06745 \| Matching products
UniProt ID :	Q9NZQ7 \| Matching products
Gene ID :	GeneID 29126 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Durvalumab"

Write a review